Literature DB >> 31532256

Are Hemorrhagic Cysts Hyperintense Enough on T1-Weighted MRI to Be Distinguished From Renal Cell Carcinomas? A Retrospective Analysis of 204 Patients.

Timothy C McKee1, Jaydev Dave1, Leann Kania1, Jay Karajgikar1,2, Venkata Masarapu1, Sandeep Deshmukh1, Christopher Roth1.   

Abstract

OBJECTIVE. The purpose of this study was to evaluate the utility of T1- and T2-weighted MRI signal-intensity ratios and signal-intensity SDs of renal lesions to determine the feasibility of distinguishing between simple cysts, hemorrhagic renal cysts, clear cell renal cell carcinoma (RCC), and papillary RCC. MATERIALS AND METHODS. Pathology records of 53 cases of papillary RCCs between 1 and 5 cm in size were included. Thirty-eight pathology-proven clear cell RCCs, 54 simple renal cysts seen on abdominal MRI, and 59 hemorrhagic renal cysts seen on abdominal MRI were identified. Lesion location and size, T1- and T2-weighted signal intensity, and corresponding SD values for each renal lesion and psoas muscle (from which lesion-to-muscle ratios were calculated) were collected. RESULTS. Analysis revealed a statistically significant difference (p < 0.001) in T1-weighted lesion-to-muscle signal-intensity ratios between simple cysts (mean ± standard error, 0.54 ± 0.05), clear cell RCCs (0.86 ± 0.06), papillary RCCs (1.17 ± 0.05), and hemorrhagic renal cysts (1.95 ± 0.04). The T2-weighted lesion-to-muscle signal-intensity ratios showed a statistically significant difference between all lesion types (p < 0.02) except between hemorrhagic renal cysts and papillary RCCs, where the difference approached significance (p = 0.075). ROC analysis showed an optimal cutoff of T1-weighted lesion-to-muscle signal-intensity ratio of 1.39 to differentiate hemorrhagic cysts (above this value) from RCCs (below this value). Corresponding sensitivity and specificity were 91.2% and 74.6%, respectively. CONCLUSION. T1-weighted lesion-to-muscle signal-intensity ratio is a useful measure to discriminate mildly hyperintense RCCs from more hyperintense hemorrhagic cysts when contrast enhancement is unavailable.

Entities:  

Keywords:  MRI; renal cell carcinoma; renal cyst

Year:  2019        PMID: 31532256     DOI: 10.2214/AJR.19.21257

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  How to improve O-RADS MRI score for rating adnexal masses with cystic component?

Authors:  Victoria Assouline; Yohann Dabi; Aurélie Jalaguier-Coudray; Sanja Stojanovic; Ingrid Millet; Caroline Reinhold; Marc Bazot; Isabelle Thomassin-Naggara
Journal:  Eur Radiol       Date:  2022-03-24       Impact factor: 7.034

2.  Can magnetic resonance imaging accurately and reliably measure humeral cortical thickness?

Authors:  Peter N Chalmers; Garrett V Christensen; Hiroaki Ishikawa; Heath B Henninger; Eugene G Kholmovski; Megan Mills; Robert Z Tashjian
Journal:  JSES Int       Date:  2021-12-11

Review 3.  Update on MRI of Cystic Renal Masses Including Bosniak Version 2019.

Authors:  Satheesh Krishna; Nicola Schieda; Ivan Pedrosa; Nicole Hindman; Ronaldo H Baroni; Stuart G Silverman; Matthew S Davenport
Journal:  J Magn Reson Imaging       Date:  2020-10-02       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.